Burahee Abdus S, Barry Veronica E, Sutcliffe Robert P, Mahroof Sabreena
Department of Orthopaedic Surgery, Royal Wolverhampton NHS Trust, WV8 1DN Wolverhampton, UK.
Liver Unit, Queen Elizabeth Hospital, Birmingham B15 2WB, UK.
SICOT J. 2021;7:5. doi: 10.1051/sicotj/2021001. Epub 2021 Feb 17.
Older patients are at increased risk of severe COVID-19 infection and associated mortality. There are limited data evaluating the outcome of older patients with hip fractures treated during the COVID-19 pandemic, and it has been suggested that these patients should be treated non-operatively due to high mortality risk. The aim of this study was to report the outcomes of COVID-19 infected hip fracture patients treated at a single centre.
This was a retrospective cohort study. Data were collected from February 2020 (after the first confirmed COVID-19 infected patient was reported in the Midlands region of the UK). All patients admitted to the hospital with femoral neck fractures were included. Patient demographics, comorbidity, COVID-19 status, and short-term clinical outcomes were obtained by review of electronic medical records. The outcomes of COVID-19 infected patients were compared with non-COVID-19 patients treated during the study period.
Twenty-nine patients were included (mean age of 80 years), of whom 14 (48%) were tested positive for COVID-19 infection in the postoperative period. Overall, 26 patients (90%) underwent surgical treatment. COVID-19 infected patients had significantly higher Charlson comorbidity scores compared to the control group (5 vs. 4; p = 0.047). Only 5 COVID-19 infected patients (36%) required supplemental oxygen therapy in the postoperative period, and no patients required respiratory or other organ support. The 30-day mortality rate in COVID-19 patients was 14% compared to 0% in the negative controls (p = 0.22).
COVID-19 infection did not increase the mortality rate of older patients undergoing surgery for hip fractures during the pandemic. The authors recommend careful assessment of patient fitness and prompt surgical treatment. In addition, it was noted that nearly all admissions were either given large boluses of Vitamin D or were on maintenance supplementation, which may have affected the severity of the response to COVID-19 infections.
老年患者发生重症 COVID-19 感染及相关死亡的风险增加。评估在 COVID-19 大流行期间接受治疗的老年髋部骨折患者的预后的数据有限,并且有人提出,由于死亡风险高,这些患者应接受非手术治疗。本研究的目的是报告在单一中心接受治疗的 COVID-19 感染髋部骨折患者的预后情况。
这是一项回顾性队列研究。数据收集自 2020 年 2 月(在英国中部地区报告首例确诊 COVID-19 感染患者之后)。纳入所有因股骨颈骨折入院的患者。通过查阅电子病历获取患者的人口统计学资料、合并症、COVID-19 状态及短期临床预后。将 COVID-19 感染患者的预后与研究期间接受治疗的非 COVID-19 患者进行比较。
共纳入 29 例患者(平均年龄 80 岁),其中 14 例(48%)在术后 COVID-19 感染检测呈阳性。总体而言,26 例患者(90%)接受了手术治疗。与对照组相比,COVID-19 感染患者的 Charlson 合并症评分显著更高(5 分对 4 分;p = 0.047)。术后仅 5 例 COVID-19 感染患者(36%)需要补充氧气治疗,无患者需要呼吸或其他器官支持。COVID-19 患者的 30 天死亡率为 14%,而阴性对照组为 0%(p = 0.22)。
COVID-19 感染并未增加大流行期间接受髋部骨折手术的老年患者的死亡率。作者建议仔细评估患者的身体状况并及时进行手术治疗。此外,还注意到几乎所有入院患者要么接受了大剂量维生素 D 治疗,要么正在进行维持补充治疗,这可能影响了对 COVID-19 感染反应的严重程度。